STOCK TITAN
  1. Home
  2. Sec-filings
  3. CCAP
  4. [Form 4] Crescent Capital BDC, Inc. Common stock Insider Trading Activity

Crescent Capital BDC (CCAP) Officer Purchase: 200 Shares Disclosed

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Crescent Capital BDC insider purchase: On 08/28/2025, reporting person Kirill Bouek, an officer and controller of Crescent Capital BDC, Inc. (CCAP), purchased 200 shares of the company’s common stock at $15.6666 per share. After the transaction, Bouek beneficially owned 1,057 shares, which includes 64 shares acquired earlier in 2025 through dividend reinvestment and not previously reported. The Form 4 was filed on 08/29/2025 and signed by George P. Hawley as attorney-in-fact. The filing is a routine Section 16 disclosure showing a small insider purchase and updated beneficial ownership.

Positive

  • Insider purchase disclosed: 200 shares acquired at $15.6666, increasing officer ownership and showing compliance with Section 16 reporting.
  • Previous dividend reinvestment clarified: 64 shares from 2025 DRIP were disclosed, correcting earlier non-reporting under Rule 16a-11.

Negative

  • None.

Insights

TL;DR: Officer acquired a small, disclosed stake: 200 shares at $15.6666, bringing total beneficial ownership to 1,057 shares.

The reported purchase is a straightforward Section 16 transaction by an officer/controller, disclosed on a Form 4. At 200 shares and a post-transaction total of 1,057 shares, the transaction size is modest relative to typical institutional holdings and does not indicate a material change in control or ownership. The inclusion of 64 dividend-reinvested shares clarifies prior omissions and aligns the filing with Rule 16 reporting requirements.

TL;DR: Compliance-focused disclosure updating beneficial ownership; no governance change implied.

The Form 4 updates the public record for an officer/controller and corrects prior omission by reporting 64 dividend-reinvested shares. The signature by an attorney-in-fact and timely filing the day after the transaction indicate standard reporting procedure. There is no indication of delegated authority issues or material governance actions from this filing alone.

Insider Bouek Kirill
Role Controller
Bought 200 shs ($3K)
Type Security Shares Price Value
Purchase Common Stock 200 $15.6666 $3K
Holdings After Transaction: Common Stock — 1,057 shares (Direct)
Footnotes (1)
  1. [object Object]
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Bouek Kirill
(Last) (First) (Middle)
299 PARK AVENUE
33RD FLOOR
(Street)
NEW YORK NY 10171
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Crescent Capital BDC, Inc. [ CCAP ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Controller
3. Date of Earliest Transaction (Month/Day/Year)
08/28/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/28/2025 08/28/2025 P 200 A $15.6666 1,057(1) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Includes 64 shares acquired through dividend reinvestment in 2025 and not previously reported pursuant to Rule 16a-11 under the Securities Act of 1934.
/s/ George P. Hawley, as Attorney-in-fact 08/29/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction was reported for Crescent Capital BDC (CCAP)?

The Form 4 reports that Kirill Bouek purchased 200 shares of CCAP common stock on 08/28/2025 at $15.6666 per share.

How many CCAP shares does the reporting person own after the transaction?

Following the transaction, the reporting person beneficially owned 1,057 shares, which includes 64 shares acquired through dividend reinvestment in 2025.

What is the reporting person’s relationship to CCAP?

The Form 4 identifies Kirill Bouek as an Officer and Controller of Crescent Capital BDC, Inc.

When was the Form 4 filed and who signed it?

The Form 4 shows the transaction date 08/28/2025 and the filing is dated 08/29/2025, signed by George P. Hawley as attorney-in-fact.

Were any prior unreported shares disclosed?

Yes. The filing states 64 shares acquired through dividend reinvestment in 2025 were not previously reported under Rule 16a-11.